|
1
|
Association of the gene encoding neurogranin with schizophrenia in males.
|
J Psychiatr Res
|
2006
|
1.16
|
|
2
|
Clinical staging in bipolar disorder: focus on cognition and functioning.
|
J Clin Psychiatry
|
2014
|
0.96
|
|
3
|
Early intervention in bipolar disorders: clinical, biochemical and neuroimaging imperatives.
|
J Affect Disord
|
2008
|
0.92
|
|
4
|
The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial.
|
J Affect Disord
|
2011
|
0.91
|
|
5
|
Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity.
|
J Psychiatr Res
|
2012
|
0.88
|
|
6
|
Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients.
|
Neurosci Lett
|
2009
|
0.86
|
|
7
|
Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial.
|
Hum Psychopharmacol
|
2009
|
0.85
|
|
8
|
Childhood trauma, impulsivity, and executive functioning in crack cocaine users.
|
Compr Psychiatry
|
2011
|
0.84
|
|
9
|
Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting.
|
CNS Spectr
|
2009
|
0.83
|
|
10
|
Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial.
|
BMC Med
|
2012
|
0.83
|
|
11
|
Naturalistic pharmacogenetic study of treatment resistance to typical neuroleptics in European-Brazilian schizophrenics.
|
Pharmacogenet Genomics
|
2008
|
0.82
|
|
12
|
The association of child abuse and neglect with adult disability in schizophrenia and the prominent role of physical neglect.
|
Child Abuse Negl
|
2009
|
0.81
|
|
13
|
Molecular diversity at the CYP2D6 locus in healthy and schizophrenic southern Brazilians.
|
Pharmacogenomics
|
2009
|
0.80
|
|
14
|
Gene expression of peripheral blood lymphocytes may discriminate patients with schizophrenia from controls.
|
Psychiatry Res
|
2012
|
0.80
|
|
15
|
Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.
|
J Psychiatr Res
|
2013
|
0.80
|
|
16
|
G-protein gene 825C>T polymorphism is associated with response to clozapine in Brazilian schizophrenics.
|
Pharmacogenomics
|
2008
|
0.79
|
|
17
|
Serum concentrations of brain-derived neurotrophic factor in patients with gender identity disorder.
|
J Psychiatr Res
|
2013
|
0.77
|
|
18
|
Verbal memory impairment in healthy siblings of patients with schizophrenia.
|
Schizophr Res
|
2013
|
0.77
|
|
19
|
Transthyretin: no association between serum levels or gene variants and schizophrenia.
|
J Psychiatr Res
|
2006
|
0.76
|
|
20
|
Influence of serotonin transporter gene polymorphisms on clozapine response in Brazilian schizophrenics.
|
J Psychiatr Res
|
2010
|
0.75
|
|
21
|
The effect of sunlight exposure on interleukin-6 levels in depressive and non-depressive subjects.
|
BMC Psychiatry
|
2013
|
0.75
|
|
22
|
α-Lipoic Acid as Adjunctive Treatment for Schizophrenia: An Open-Label Trial.
|
J Clin Psychopharmacol
|
2017
|
0.75
|
|
23
|
Family-based and case-control studies reveal no association of lipocalin-type prostaglandin D2 synthase with schizophrenia.
|
Am J Med Genet B Neuropsychiatr Genet
|
2007
|
0.75
|
|
24
|
Elevated serum protein oxidative stress in siblings of patients with schizophrenia.
|
Schizophr Res
|
2013
|
0.75
|